Cidara Therapeutics Presents New Promising Preclincal Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress
Stock Information for Cidara Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.